March 29 2023 - J&J bows out of RSV vaccine race after scrapping trial
Careers Information from across the Internet
×
Attorney
Engineering
Healthcare Workers
HVAC Technicians
Plumbing Services
Accountants
Teachers
HR Management
Scientists
Data Security Experts
Consultants
Report Site
Privacy Policy
Terms And Conditions
View All Posts
Subscribe To Our Newsletter
Menu
Careers Information from across the Internet
Attorney
Doctors
Logistics
Financial Advisors
Software Developers
March 29 2023 - J&J bows out of RSV vaccine race after scrapping trial
J&J bows out of RSV vaccine race after scrapping trial Former FDA official says agency dysfunction ..
January 23 2024 - Sickle cell gene therapies seen as cost effective below $2M threshold
Sickle cell gene therapies seen as cost effective below $2M threshold FDA requires 'boxed warning' ..
January 29 2024 - AstraZeneca, Daiichi aim for first pan-tumor ADC approval
AstraZeneca, Daiichi aim for first pan-tumor ADC approval Moderna leads development of mRNA..
January 30 2024 - Pfizer posts surprise 4th quarter profit, but key products miss on sales
Pfizer posts surprise 4th quarter profit, but key products miss on sales Cour gets $105M, pharma..
December 21 2023 - Merck’s chronic cough drug fails to secure FDA approval for the second time
Merck’s chronic cough drug fails to secure FDA approval for the second time FDA denies accelerated ..
November 21 2023 - Merck drops up to $610M on neuro disease-focused Caraway Therapeutics
Merck drops up to $610M on neuro disease-focused Caraway Therapeutics Biohaven hopes to muscle in..
November 30 2023 - AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field Biopharma’s top 5 ..
October 31 2023 - The 2023 Biotech Graveyard
The 2023 Biotech Graveyard GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy ..
August 18 2023 - Biogen kicks off 1,000 layoffs as part of CEO Viehbacher’s ‘complete redesign’
Biogen kicks off 1,000 layoffs as part of CEO Viehbacher’s ‘complete redesign’ Novartis floats..
August 30 2023 - Novo Nordisk bolsters obesity pipeline with potential $500M Embark Biotech buy
Novo Nordisk bolsters obesity pipeline with potential $500M Embark Biotech buy AmerisourceBergen..
August 31 2023 - Sage lays off 40%, shakes up C-suite to squeeze a profit out of partially rejected ..
Sage lays off 40%, shakes up C-suite to squeeze a profit out of partially rejected zuranolone ..
July 19 2023 - Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt AI policymaking needs more voices ..
July 26 2023 - GSK expects slower uptake of RSV vaccine amid record sales of shingles shot
GSK expects slower uptake of RSV vaccine amid record sales of shingles shot AbbVie's Skyrizi..
April 20 2023 - BMS signs ADC development deal with Munich-based biotech worth more than $1B
BMS signs ADC development deal with Munich-based biotech worth more than $1B BeiGene's gastric..
Specialty Services Offered by Pharmacies in Orange County, CA
At UCI Health Outpatient Specialty Pharmacy, we offer a wide range of specialty services to meet..
March 21 2023 - FDA's Peter Marks backs accelerated approval for gene therapies
FDA's Peter Marks backs accelerated approval for gene therapies Return of the megaround: is..
March 1 2023 - Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with..
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance ..
March 6 2023 - FDA sets July decision date for full approval of Leqembi
FDA sets July decision date for full approval of Leqembi FDA widens Lilly's Verzenio breast cancer ..
February 15 2023 - Brent Saunders to return as Bausch + Lomb CEO
Brent Saunders to return as Bausch + Lomb CEO Bavarian Nordic to acquire portfolio of travel..
February 22 2023 - Medtronic growth catalysts for 2023
Medtronic growth catalysts for 2023 After a standout IPO and series of pivots, Rubius closes its..
previous post
